Global Markets for Diabetes Therapeutics and Diagnostics

This report provides:

• An overview of the global market for diabetes therapies and diagnostics
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Updates on merger and acquisition (M&A) activities
• Breakdowns of several national markets
• Information on research and development (R&D) trends
• Examination of healthcare policies, demographics, and the wider economic enviroment
• Comprehensive company profiles of major players in the relevant pharmaceutical and medical industries.

Use this report to:

• Forecast the market size for diabetes therapeutics and diagnostics in terms of dollar and unit sales.
• Classify the market size for diabetes therapeutics and diagnostics by geographical regions in terms of dollar and unit sales.
• Highlight the roles played by major stakeholders and players.
• Examine crucial, innovative breakthroughs by means of a detailed patent analysis.

SAMPLE FIGURE

DIABETES MARKET EVOLUTION BY REGION, 2011-2017

($ BILLIONS)

 

 Source: BCC Research

Global market for diabetes therapies and diagnostics worth $51.2 billion by 2015

The global market for diabetes therapies and diagnostics was about $35.5 billion in 2009 and is expected to reach $38 billion in 2010 and $51.2 billion by 2015, a compound annual growth rate (CAGR) of 6.1% over the next 5 years.


Learn about the important trends in the global market for diabetes therapies and diagnostics. Get sales forecasts by product categories and major country markets through 2015 plus information on R&D trends and differential market potential on a country-by-country basis. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity...

Use this report to:

• Understand the current extent of the diabetes epidemic, its likely evolution over the next 5 years, and the impact of drugs and technical developments now in the pipeline
• Quantify and qualify the market for prescription branded and generic drugs used to treat diabetes as well as devices and instruments used to diagnose and monitor diabetes
• Formulate business and marketing strategies based on sales forecasts by product categories, epidemiological data and projections, R&D trends, and differential market potential on a country-by-country basis.
• Learn about the key issues influencing this field, such as healthcare policies, demographics, and the wider economic environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.